VBP in the UK is around the corner and Hanson Wade (see post below) have invited Olivier and myself to run a pre-conference workshop on VBP. Looking forward to seeing many of you!
At Value Based Pricing (24 - 26 September, London) authors of The Future of Health Economics, Ulf Staginnus and Olivier Ethgen will be leading an introductory workshop to get you up to speed on the considerations and implications surrounding value-based pricing. This interactive session will enable you to practically implement value-based strategies into your drug development programmes and ensure you meet the growing demands of payers around Europe.
Attend their interactive half-day workshop to:
- Explore what a VBP structure will mean for the UK - get to grips with the changing pricing structure and understand how it relates to other EU countries
- Evaluate the practicalities of incorporating VBP into your strategies and realise what is achievable for your portfolios
- Understand how value can be defined and whether it should be consistent across disease indications and patient populations
- Discuss international reference pricing in relation to value-based pricing
Download the brochure to see the full Value Based Pricing agenda and information on the other 2 workshops.
Following on from the workshop day, Value Based Pricing will feature companies working across Germany, France, Switzerland, The Netherlands, Belgium and the UK openly sharing their experiences of developing value-based pricing strategies, preparing you for the impending pricing changes in the UK.
This meeting represents your greatest chance to be as prepared as possible for a value based pricing system in the UK and across Europe. Join your peers at Bayer, Vifor Pharma, Novartis, Ipsen Pharma, InterMune, GSK, Merck Serono, Takeda, Bristol-Myers Squibb, Pfizer and Amgen among others.
Register before Friday 28th June to save up to £300 off standard rates. To secure your place, visit: www.valuebased-pricing.com/register